Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Inflammatory Bowel Diseases|October 12, 2004
A pilot study of adalimumab in infliximab-allergic patientsAdrienne Youdim, Eric A Vasiliauskas, Stephan R Targan, et al.
Frontiers in Immunology|October 28, 2024
Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8<sup>+</sup> T cellsHussein Hamade, Masato Tsuda, Naoki Oshima, et al.
Gastroenterology|October 1, 2013
Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's diseaseKelli L VanDussen, Ta-Chiang Liu, Dalin Li, et al.
Antimicrobial Agents and Chemotherapy|June 11, 2014
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel DiseaseHenry A Horton, Seper Dezfoli, Dror Berel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's DiseaseJean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, et al.
Gastroenterology|July 19, 2011
Cathelicidin signaling via the Toll-like receptor protects against colitis in miceHon Wai Koon, David Q Shih, Jeremy Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Gut|July 5, 2012
The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in miceTressia C Hing, Samantha Ho, David Q Shih, et al.
Gastroenterology|August 29, 2002
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's diseaseMaria T Abreu, Kent D Taylor, Ying-Chao Lin, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Inflammatory Bowel Diseases|October 12, 2004
A pilot study of adalimumab in infliximab-allergic patientsAdrienne Youdim, Eric A Vasiliauskas, Stephan R Targan, et al.
Frontiers in Immunology|October 28, 2024
Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8<sup>+</sup> T cellsHussein Hamade, Masato Tsuda, Naoki Oshima, et al.
Gastroenterology|October 1, 2013
Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's diseaseKelli L VanDussen, Ta-Chiang Liu, Dalin Li, et al.
Antimicrobial Agents and Chemotherapy|June 11, 2014
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel DiseaseHenry A Horton, Seper Dezfoli, Dror Berel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's DiseaseJean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, et al.
Gastroenterology|July 19, 2011
Cathelicidin signaling via the Toll-like receptor protects against colitis in miceHon Wai Koon, David Q Shih, Jeremy Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Gut|July 5, 2012
The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in miceTressia C Hing, Samantha Ho, David Q Shih, et al.
Gastroenterology|August 29, 2002
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's diseaseMaria T Abreu, Kent D Taylor, Ying-Chao Lin, et al.
Pageof 19